Moffitt Cancer Center: Why we are building the first machine learning department in oncology

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Imagine a future where cancer patients are able to receive the treatment they precisely need and not the treatment that is prescribed to all.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Issam El Naqa, PhD
Chair, Department of Machine Learning, Moffitt Cancer Center
Dana Rollison, PhD
Vice president, chief data officer, associate center director of data science, Division chief, quantitative science, Moffitt Cancer Center
Table of Contents

YOU MAY BE INTERESTED IN

Despite steady progress in reducing overall cancer mortality rates, cancer incidence in women is rising, according to the American Cancer Society’s “Cancer Statistics, 2025” report. Incidence rates in women 50-64 years of age have surpassed those in men, and rates in women under 50 are now 82% higher than their male counterparts, up from 51% higher in 2002. In 2021, for the first time, lung cancer incidence was higher in women under 65 than in men. 
Over the past five years, Cedars-Sinai Cancer has built an integrated, regional system designed to provide cancer care close to where patients live and work. This model of care, directed by an academic medical center to patients at the community level, proved to be the best possible approach to supporting patients in our 11-million-person catchment area during the worst fire disaster in California history. 
Issam El Naqa, PhD
Chair, Department of Machine Learning, Moffitt Cancer Center
Dana Rollison, PhD
Vice president, chief data officer, associate center director of data science, Division chief, quantitative science, Moffitt Cancer Center

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login